Prolight Gets Intention to Grant Notices for Two European Diagnostic Technology Patents

03:41 AM EDT, 10/29/2026 (MT Newswires) -- Prolight Diagnostics (PRLD.ST) received intention-to-grant notifications from the European Patent Office for two patent applications covering its Psyros single-molecule-counting diagnostics platform, according to a Thursday release. The point-of-care systems developer said the applications cover multiplexing, which enables simultaneous measurement of multiple biomarkers without cross-reactivity, and dynamic range, which allows measurements across biomarker concentrations while maintaining sensitivity. The technologies are complementary and can be combined in diagnostic tests.